TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $6,412,000 | -10.9% | 4,588,500 | -5.6% | 0.01% | -16.7% |
| Q1 2015 | $7,197,000 | -0.3% | 4,863,000 | -8.0% | 0.01% | -14.3% |
| Q4 2014 | $7,218,000 | +1.3% | 5,283,000 | -4.8% | 0.01% | -12.5% |
| Q3 2014 | $7,122,000 | -4.1% | 5,548,000 | -4.5% | 0.01% | -11.1% |
| Q2 2014 | $7,428,000 | -0.6% | 5,812,000 | -1.3% | 0.01% | -10.0% |
| Q1 2014 | $7,475,000 | +21.1% | 5,888,000 | +1.3% | 0.01% | +25.0% |
| Q4 2013 | $6,173,000 | -0.5% | 5,813,000 | -2.8% | 0.01% | -11.1% |
| Q3 2013 | $6,202,000 | -1.9% | 5,981,000 | -0.9% | 0.01% | -10.0% |
| Q2 2013 | $6,319,000 | – | 6,033,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 91,833,000 | $98,950,000 | 5.16% |
| Ferox Capital Management LP | 5,390,000 | $5,796,000 | 2.37% |
| INCOME RESEARCH & MANAGEMENT | 7,472,000 | $8,014,000 | 2.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 14,535 | $8,641,000 | 1.47% |
| Lombard Odier Asset Management (Europe) Ltd | 21,660,000 | $23,433,000 | 1.33% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,864,000 | $12,783,000 | 1.15% |
| MACKAY SHIELDS LLC | 18,887,000 | $20,335,000 | 0.86% |
| AEGON USA Investment Management, LLC | 4,000,000 | $4,290,000 | 0.84% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 32,751,000 | $35,196,000 | 0.67% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,067,000 | $6,522,000 | 0.24% |